Abstract
Much remains unclear about the benefits and harms of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Between 2012 and 2018, we conducted two Cochrane systematic reviews on methylphenidate for ADHD. This article explores the main findings in relation to evidence-based practice and our current understanding of ADHD.
| Bidragets oversatte titel | 基于发病机制治疗遗传性神经发育障碍的未来之路 |
|---|---|
| Originalsprog | Engelsk |
| Tidsskrift | Clinical Pharmacology and Therapeutics |
| Vol/bind | 104 |
| Udgave nummer | 4 |
| Sider (fra-til) | 606-609 |
| ISSN | 0009-9236 |
| DOI | |
| Status | Udgivet - 13 jul. 2018 |
Fingeraftryk
Dyk ned i forskningsemnerne om '基于发病机制治疗遗传性神经发育障碍的未来之路'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS